BR112014001404A2 - produto para a nutrição parenteral de pacientes de tratamento intensivo obesos - Google Patents

produto para a nutrição parenteral de pacientes de tratamento intensivo obesos

Info

Publication number
BR112014001404A2
BR112014001404A2 BR112014001404A BR112014001404A BR112014001404A2 BR 112014001404 A2 BR112014001404 A2 BR 112014001404A2 BR 112014001404 A BR112014001404 A BR 112014001404A BR 112014001404 A BR112014001404 A BR 112014001404A BR 112014001404 A2 BR112014001404 A2 BR 112014001404A2
Authority
BR
Brazil
Prior art keywords
parenteral nutrition
intensive care
care patients
obese intensive
nutrition product
Prior art date
Application number
BR112014001404A
Other languages
English (en)
Inventor
Schlotzer Ewald
Abele Rosa
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47555035&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014001404(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of BR112014001404A2 publication Critical patent/BR112014001404A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Pediatric Medicine (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

resumo patente de invenção : "produto para a nutrição parenteral de pacientes de tratamento intensivo obesos". a presente invenção refere-se a uma solução de nutrição parenteral pobre em lipídios e carboidratos, rica em aminoácidos para administrar a pacientes de tratamento intensivo obesos, bem como a uma bolsa de três câmaras, que compreende o componente de aminoácidos, o componente de carboidratos e o componente de lipídios da solução de nutrição parenteral separados uns dos outros em três diferentes câmaras.
BR112014001404A 2011-07-22 2012-07-19 produto para a nutrição parenteral de pacientes de tratamento intensivo obesos BR112014001404A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161510512P 2011-07-22 2011-07-22
EP11175036 2011-07-22
PCT/EP2012/064220 WO2013014064A1 (de) 2011-07-22 2012-07-19 Produkt zur parenteralen ernährung von adipösen intensivpatienten

Publications (1)

Publication Number Publication Date
BR112014001404A2 true BR112014001404A2 (pt) 2017-03-01

Family

ID=47555035

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014001404A BR112014001404A2 (pt) 2011-07-22 2012-07-19 produto para a nutrição parenteral de pacientes de tratamento intensivo obesos

Country Status (7)

Country Link
US (2) US20130020226A1 (pt)
EP (1) EP2734217B1 (pt)
KR (1) KR102007177B1 (pt)
CN (1) CN103717230A (pt)
BR (1) BR112014001404A2 (pt)
MX (1) MX363827B (pt)
WO (1) WO2013014064A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015003021A2 (en) * 2013-07-01 2015-01-08 The Trustees Of Princeton University Dietary supplements and composition for treating cancer
FR3027074B1 (fr) * 2014-10-14 2016-12-09 Snecma Procede de fabrication d'un palier fluide hydrostatique alveole
CN112402461A (zh) * 2015-11-06 2021-02-26 王益超 一种用于治疗孤独症社会交往障碍的组合物
CN108369223B (zh) * 2015-12-30 2021-07-06 雀巢产品有限公司 用于测定去脂体重的方法
CN110785815B (zh) 2017-05-09 2023-06-27 巴克斯特国际公司 胃肠外营养诊断系统、设备和方法
US20210212936A1 (en) * 2018-06-01 2021-07-15 Baxter International Inc. Parenteral nutrition formulation
US11278510B2 (en) 2019-09-05 2022-03-22 Baxter International Inc. Parenteral nutrition formulation with optimized amino acid and glucose content
WO2023117871A1 (en) * 2021-12-21 2023-06-29 Fresenius Kabi Deutschland Gmbh Compositions for providing parenteral nutrition to pediatric patients

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5189016A (en) * 1990-05-18 1993-02-23 Clintec Nutrition Co. Nutrient compositions containing peptides and method for administering the same
US6039989A (en) * 1995-06-06 2000-03-21 Campbell Soup Company Prepackaged therapeutic meal for treatment of diet-responsive conditions
CA2222278C (en) 1995-06-06 2008-05-13 Campbell Soup Company Mineral supplements for dietetic food
ZA978002B (en) * 1996-09-11 1998-03-02 Baxter Int Containers and methods for storing and admixing medical solutions.
GB0229838D0 (en) * 2002-12-20 2003-01-29 Mars Uk Ltd Multi-component meal
EP2311448A1 (en) 2003-12-24 2011-04-20 N.V. Nutricia Compositions comprising pantothenic acid or derivatives thereof and their use for stimulating appetite
JP5702042B2 (ja) 2004-04-09 2015-04-15 エヌ．ブイ．・ヌートリシア 濃縮液状調製物
ES2402935T3 (es) * 2005-03-21 2013-05-10 Abbott Laboratories Composición de aminoácidos para mejorar la tolerancia a la glucosa
RU2437655C2 (ru) 2006-01-09 2011-12-27 Нестек С.А. Лечение пациентов, подвергнутых стрессу

Also Published As

Publication number Publication date
KR102007177B1 (ko) 2019-08-05
MX2014000857A (es) 2014-04-30
US20130020226A1 (en) 2013-01-24
US20140205673A1 (en) 2014-07-24
MX363827B (es) 2019-04-03
WO2013014064A1 (de) 2013-01-31
CN103717230A (zh) 2014-04-09
KR20140060503A (ko) 2014-05-20
EP2734217A1 (de) 2014-05-28
EP2734217B1 (de) 2020-12-02

Similar Documents

Publication Publication Date Title
BR112014001404A2 (pt) produto para a nutrição parenteral de pacientes de tratamento intensivo obesos
CY1117183T1 (el) Διακλαδισμενα παραγωγα 3-φαινυλοπροπιονικου οξεος και η χρηση τους
BR112015014800A2 (pt) derivados da exendina-4 funcionalizada
BR112014016810A2 (pt) composições e métodos para tratamento de distúrbios metabólicos
BR112015016358A2 (pt) composições nutritivas contendo um componente neurológico e usos das mesmas
EP3682875A3 (en) Methods of treating pediatric metabolic syndrome
MX2014009757A (es) Derivados de isoindolina, composiciones farmaceuticas que los contienen y su uso en terapia.
TN2014000175A1 (en) Novel purine derivatives and their use in the treatment of disease
BR112014033102A2 (pt) produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido
MX357780B (es) Derivados policíclicos, proceso para su preparación y su uso farmacéutico.
BR112015004501A2 (pt) derivado de ácido hialurônico tendo aminoácidos e grupos esterila introduzidos no mesmo
BR112015007647A2 (pt) derivados de quetamina
BR112014031204A2 (pt) derivados deuterados de ruxolitinib
ECSP15001892A (es) Manejo dietético de la enfermedad celíaca y alergia a los alimentos
BR112013029256A8 (pt) combinação farmacêutica para uso no tratamento de pacientes com diabetes tipo 2
BR112016007536A2 (pt) compostos, composições e utilizações correspondentes, para a prevenção e/ou o tratamento de dislipidemias
BR112013017314A2 (pt) composições compreendendo inibidores de cotransportadores 1 e 2 de sódio-glicose e métodos de usos
BR112015017251A2 (pt) composições farmacêuticas compreendendo doadores de nitroxil
BR112014002025A2 (pt) partículas que compreendem compostos ativos com base em poliacrilato
BR112013030264A2 (pt) ácidos acéticos de benzociclohepteno
BR112013028820A2 (pt) alimento medicinal para declínio cognitivo
BR112013018298A2 (pt) compostos para a redução da produção de beta-amiloides
BR112012022109A2 (pt) derivados de aminoindanos, seu preparo e sua aplicação em produtos terapêuticos
BR112014000889A2 (pt) tratamento para hipoxia
BR112014000599A2 (pt) sistema dietético multicomponentes

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 9/00 (2006.01), A23L 33/175 (2016.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]